{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:32:58Z","timestamp":1788201178216,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The excessive accumulation of extracellular matrix (ECM) is a hallmark of renal interstitial fibrosis, its underlying mechanisms are incompletely understood. Here, we identify the E3 ubiquitin ligase Tripartite motif-containing protein 21 (Trim21) as a key regulator of this process. We found that Trim21 is upregulated in the tubular cells of fibrotic kidneys from both chronic kidney disease (CKD) patients and mouse models. Using tubular cell-specific Trim21 knockout mice, we demonstrated that Trim21 induction protects against ECM accumulation and renal fibrosis. Mechanistically, Trim21 binds to the N-terminal domain of Lysyl Oxidase-like 2 (Loxl2), promoting its ubiquitination and degradation, which in turn alleviates ECM deposition. Furthermore, we observed an upregulation of interferon-\u03b3 (IFN-\u03b3) and its receptor in tubular cells during fibrosis. IFN-\u03b3 treatment increased Trim21 expression, reduced Loxl2 expression and renal fibrosis; critically, this protective effect was abolished in tubular-specific Trim21 knockout mice. In summary, our study defines a protective IFN-\u03b3\/Trim21\/Loxl2 axis in the kidney, wherein IFN-\u03b3 signaling induces Trim21 to target Loxl2 for degradation, thereby mitigating fibrosis.<\/jats:p>","DOI":"10.1038\/s41419-026-08850-7","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:46:24Z","timestamp":1778679984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pro-inflammatory cytokine IFN-\u03b3 protects against renal fibrosis by promoting E3 ubiquitin ligase Trim21-mediated Loxl2 degradation in tubular epithelial cells"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8376-0094","authenticated-orcid":false,"given":"Hanlu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengru","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7616-2469","authenticated-orcid":false,"given":"Chunsun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"8850_CR1","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","volume":"322","author":"T Chen","year":"2019","unstructured":"Chen T, Knicely D, Grams M. Chronic kidney disease diagnosis and management: a review. JAMA. 2019;322:1294\u2013304.","journal-title":"JAMA"},{"key":"8850_CR2","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1440-1797.2006.00575.x","volume":"11","author":"PE de Jong","year":"2006","unstructured":"de Jong PE, Gansevoort RT. Prevention of chronic kidney disease: the next step forward!. Nephrol (Carlton). 2006;11:240\u20134.","journal-title":"Nephrol (Carlton)"},{"key":"8850_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.kisu.2017.07.007","volume":"7","author":"AK Bello","year":"2017","unstructured":"Bello AK, Alrukhaimi M, Ashuntantang GE, Basnet S, Rotter RC, Douthat WG, et al. Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action. Kidney Int Suppl. 2017;7:122\u20139.","journal-title":"Kidney Int Suppl"},{"key":"8850_CR4","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41581-022-00590-z","volume":"18","author":"L Li","year":"2022","unstructured":"Li L, Fu H, Liu Y. The fibrogenic niche in kidney fibrosis: components and mechanisms. Nat Rev Nephrol. 2022;18:545\u201357.","journal-title":"Nat Rev Nephrol"},{"key":"8850_CR5","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/path.4104","volume":"229","author":"F Klingberg","year":"2013","unstructured":"Klingberg F, Hinz B, White ES. The myofibroblast matrix: implications for tissue repair and fibrosis. J Pathol. 2013;229:298\u2013309.","journal-title":"J Pathol"},{"key":"8850_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41581-022-00553-4","volume":"18","author":"F Schreibing","year":"2022","unstructured":"Schreibing F, Kramann R. Mapping the human kidney using single-cell genomics. Nat Rev Nephrol. 2022;18:347\u201360.","journal-title":"Nat Rev Nephrol"},{"key":"8850_CR7","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/s41590-019-0386-1","volume":"20","author":"E Der","year":"2019","unstructured":"Der E, Suryawanshi H, Morozov P, Kustagi M, Goilav B, Ranabothu S, et al. Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways. Nat Immunol. 2019;20:915\u201327.","journal-title":"Nat Immunol"},{"key":"8850_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1189\/jlb.0603252","volume":"75","author":"K Schroder","year":"2004","unstructured":"Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004;75:163\u201389.","journal-title":"J Leukoc Biol"},{"key":"8850_CR9","doi-asserted-by":"publisher","first-page":"761.e768","DOI":"10.1016\/j.urology.2010.10.015","volume":"77","author":"Y Yao","year":"2011","unstructured":"Yao Y, Zhang J, Tan DQ, Chen XY, Ye DF, Peng JP, et al. Interferon-\u03b3 improves renal interstitial fibrosis and decreases intrarenal vascular resistance of hydronephrosis in an animal model. Urology. 2011;77:761.e768\u2013713.","journal-title":"Urology"},{"key":"8850_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.kint.2017.02.006","volume":"92","author":"BMP Law","year":"2017","unstructured":"Law BMP, Wilkinson R, Wang X, Kildey K, Lindner M, Rist MJ, et al. Interferon-\u03b3 production by tubulointerstitial human CD56(bright) natural killer cells contributes to renal fibrosis and chronic kidney disease progression. Kidney Int. 2017;92:79\u201388.","journal-title":"Kidney Int"},{"key":"8850_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79664-6","volume":"11","author":"R Kanai","year":"2021","unstructured":"Kanai R, Nakashima A, Doi S, Kimura T, Yoshida K, Maeda S, et al. Interferon-\u03b3 enhances the therapeutic effect of mesenchymal stem cells on experimental renal fibrosis. Sci Rep. 2021;11:850.","journal-title":"Sci Rep"},{"key":"8850_CR12","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1046\/j.1523-1755.1999.00775.x","volume":"56","author":"SD Oldroyd","year":"1999","unstructured":"Oldroyd SD, Thomas GL, Gabbiani G, El Nahas AM. Interferon-gamma inhibits experimental renal fibrosis. Kidney Int. 1999;56:2116\u201327.","journal-title":"Kidney Int"},{"key":"8850_CR13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI151189","volume":"132","author":"MG Kim","year":"2022","unstructured":"Kim MG, Yun D, Kang CL, Hong M, Hwang J, Moon KC, et al. Kidney VISTA prevents IFN-\u03b3\/IL-9 axis-mediated tubulointerstitial fibrosis after acute glomerular injury. J Clin Invest. 2022;132:e151189.","journal-title":"J Clin Invest"},{"key":"8850_CR14","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1006\/jmbi.1999.3429","volume":"295","author":"KL Borden","year":"2000","unstructured":"Borden KL. RING domains: master builders of molecular scaffolds? J Mol Biol. 2000;295:1103\u201312.","journal-title":"J Mol Biol"},{"key":"8850_CR15","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nri2413","volume":"8","author":"K Ozato","year":"2008","unstructured":"Ozato K, Shin DM, Chang TH, Morse HC TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol. 2008;8:849\u201360.","journal-title":"Nat Rev Immunol"},{"key":"8850_CR16","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.jmb.2006.02.009","volume":"358","author":"MA Massiah","year":"2006","unstructured":"Massiah MA, Simmons BN, Short KM, Cox TC. Solution structure of the RBCC\/TRIM B-box1 domain of human MID1: B-box with a RING. J Mol Biol. 2006;358:532\u201345.","journal-title":"J Mol Biol"},{"key":"8850_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21443-6","volume":"12","author":"L Kiss","year":"2021","unstructured":"Kiss L, Clift D, Renner N, Neuhaus D, James LC. RING domains act as both substrate and enzyme in a catalytic arrangement to drive self-anchored ubiquitination. Nat Commun. 2021;12:1220.","journal-title":"Nat Commun"},{"key":"8850_CR18","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/cr.2014.46","volume":"24","author":"Y Li","year":"2014","unstructured":"Li Y, Wu H, Wu W, Zhuo W, Liu W, Zhang Y, et al. Structural insights into the TRIM family of ubiquitin E3 ligases. Cell Res. 2014;24:762\u20135.","journal-title":"Cell Res"},{"key":"8850_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.febslet.2005.11.076","volume":"580","author":"C Gr\u00fctter","year":"2006","unstructured":"Gr\u00fctter C, Briand C, Capitani G, Mittl PR, Papin S, Tschopp J, et al. Structure of the PRYSPRY-domain: implications for autoinflammatory diseases. FEBS Lett. 2006;580:99\u2013106.","journal-title":"FEBS Lett"},{"key":"8850_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.11.043","volume":"51","author":"Y Li","year":"2020","unstructured":"Li Y, Ren D, Shen Y, Zheng X, Xu G. Altered DNA methylation of TRIM13 in diabetic nephropathy suppresses mesangial collagen synthesis by promoting ubiquitination of CHOP. EBioMedicine. 2020;51:102582.","journal-title":"EBioMedicine"},{"key":"8850_CR21","doi-asserted-by":"publisher","first-page":"11555","DOI":"10.1002\/jcp.27810","volume":"234","author":"J Liu","year":"2019","unstructured":"Liu J, Feng X, Tian Y, Wang K, Gao F, Yang L, et al. Knockdown of TRIM27 expression suppresses the dysfunction of mesangial cells in lupus nephritis by FoxO1 pathway. J Cell Physiol. 2019;234:11555\u201366.","journal-title":"J Cell Physiol"},{"key":"8850_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41420-023-01785-4","volume":"10","author":"J Jian","year":"2024","unstructured":"Jian J, Liu Y, Zheng Q, Wang J, Jiang Z, Liu X, et al. The E3 ubiquitin ligase TRIM39 modulates renal fibrosis induced by unilateral ureteral obstruction through regulating proteasomal degradation of PRDX3. Cell Death Discov. 2024;10:17.","journal-title":"Cell Death Discov"},{"key":"8850_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.616747","volume":"8","author":"W Liu","year":"2020","unstructured":"Liu W, Yi Y, Zhang C, Zhou B, Liao L, Liu W, et al. The expression of TRIM6 activates the mTORC1 pathway by regulating the ubiquitination of TSC1-TSC2 to promote renal fibrosis. Front Cell Dev Biol. 2020;8:616747.","journal-title":"Front Cell Dev Biol"},{"key":"8850_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.kint.2021.09.027","volume":"101","author":"H Li","year":"2022","unstructured":"Li H, Duann P, Li Z, Zhou X, Ma J, Rovin BH, et al. The cell membrane repair protein MG53 modulates transcription factor NF-\u03baB signaling to control kidney fibrosis. Kidney Int. 2022;101:119\u201330.","journal-title":"Kidney Int"},{"key":"8850_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.709506","volume":"12","author":"Q Chen","year":"2021","unstructured":"Chen Q, Gao C, Wang M, Fei X, Zhao N. TRIM18-regulated STAT3 signaling pathway via PTP1B promotes renal epithelial-mesenchymal transition, inflammation, and fibrosis in diabetic kidney disease. Front Physiol. 2021;12:709506.","journal-title":"Front Physiol"},{"key":"8850_CR26","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1084\/jem.20090585","volume":"206","author":"A Espinosa","year":"2009","unstructured":"Espinosa A, Dardalhon V, Brauner S, Ambrosi A, Higgs R, Quintana FJ, et al. Loss of the lupus autoantigen Ro52\/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. J Exp Med. 2009;206:1661\u201371.","journal-title":"J Exp Med"},{"key":"8850_CR27","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.163795","volume":"7","author":"E Gomez-Ba\u00f1uelos","year":"2022","unstructured":"Gomez-Ba\u00f1uelos E, Wahadat MJ, Li J, Paz M, Antiochos B, Celia AI, et al. Alternative exon usage in TRIM21 determines the antigenicity of Ro52\/TRIM21 in systemic lupus erythematosus. JCI Insight. 2022;7:e163795.","journal-title":"JCI Insight"},{"key":"8850_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/ni.2548","volume":"14","author":"WA McEwan","year":"2013","unstructured":"McEwan WA, Tam JC, Watkinson RE, Bidgood SR, Mallery DL, James LC. Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21. Nat Immunol. 2013;14:327\u201336.","journal-title":"Nat Immunol"},{"key":"8850_CR29","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/ni.2492","volume":"14","author":"Z Zhang","year":"2013","unstructured":"Zhang Z, Bao M, Lu N, Weng L, Yuan B, Liu YJ. The E3 ubiquitin ligase TRIM21 negatively regulates the innate immune response to intracellular double-stranded DNA. Nat Immunol. 2013;14:172\u20138.","journal-title":"Nat Immunol"},{"key":"8850_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.canlet.2021.03.023","volume":"508","author":"X Chen","year":"2021","unstructured":"Chen X, Li Z, Yong H, Wang W, Wang D, Chu S, et al. Trim21-mediated HIF-1\u03b1 degradation attenuates aerobic glycolysis to inhibit renal cancer tumorigenesis and metastasis. Cancer Lett. 2021;508:115\u201326.","journal-title":"Cancer Lett"},{"key":"8850_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13046-022-02583-z","volume":"42","author":"X Chen","year":"2023","unstructured":"Chen X, Yong H, Chen M, Deng C, Wang P, Chu S, et al. TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability. J Exp Clin Cancer Res. 2023;42:34.","journal-title":"J Exp Clin Cancer Res"},{"key":"8850_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105739","volume":"116","author":"ML Ji","year":"2025","unstructured":"Ji ML, Wang JN, Wu MF, Xu CH, Zhang MM, Chang WB, et al. Targeting Stat3 with conditional knockout or PROTAC technology alleviates renal injury by Limiting pyroptosis. EBioMedicine. 2025;116:105739.","journal-title":"EBioMedicine"},{"key":"8850_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121608","volume":"321","author":"X Sun","year":"2023","unstructured":"Sun X, Huang N, Li P, Dong X, Yang J, Zhang X, et al. TRIM21 ubiquitylates GPX4 and promotes ferroptosis to aggravate ischemia\/reperfusion-induced acute kidney injury. Life Sci. 2023;321:121608.","journal-title":"Life Sci"},{"key":"8850_CR34","doi-asserted-by":"publisher","first-page":"116822.","DOI":"10.1016\/j.bcp.2025.116822","volume":"234","author":"P Li","year":"2025","unstructured":"Li P, Dong X, Xu L, Hu X, Meng X, Yang P, et al. TRIM21 knockout alleviates renal fibrosis by promoting autophagic degradation of mature TGF-\u03b21. Biochem Pharm. 2025;234:116822.","journal-title":"Biochem Pharm"},{"key":"8850_CR35","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.kint.2022.03.024","volume":"102","author":"M Gu","year":"2022","unstructured":"Gu M, Tan M, Zhou L, Sun X, Lu Q, Wang M, et al. Protein phosphatase 2Ac\u03b1 modulates fatty acid oxidation and glycolysis to determine tubular cell fate and kidney injury. Kidney Int. 2022;102:321\u201336.","journal-title":"Kidney Int"},{"key":"8850_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.31439","volume":"239","author":"Y Wen","year":"2024","unstructured":"Wen Y, Tian M, Jiang X, Gong Y, Gan H. Trim21 mediates metabolic reprogramming in renal tubular cells via PFKP ubiquitination to alleviate renal fibrosis. J Cell Physiol. 2024;239:e31439.","journal-title":"J Cell Physiol"},{"key":"8850_CR37","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"XM Meng","year":"2016","unstructured":"Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-\u03b2: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12:325\u201338.","journal-title":"Nat Rev Nephrol"},{"key":"8850_CR38","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/hep.31236","volume":"72","author":"W Chen","year":"2020","unstructured":"Chen W, Yang A, Jia J, Popov YV, Schuppan D, You H. Lysyl oxidase (LOX) family members: rationale and their potential as therapeutic targets for liver fibrosis. Hepatology. 2020;72:729\u201341.","journal-title":"Hepatology"},{"key":"8850_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188435","volume":"1874","author":"B Wen","year":"2020","unstructured":"Wen B, Xu LY, Li EM. LOXL2 in cancer: regulation, downstream effectors and novel roles. Biochim Biophys Acta Rev Cancer. 2020;1874:188435.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"8850_CR40","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s10875-007-9157-0","volume":"28","author":"L Strandberg","year":"2008","unstructured":"Strandberg L, Ambrosi A, Espinosa A, Ottosson L, Eloranta ML, Zhou W, et al. Interferon-alpha induces up-regulation and nuclear translocation of the Ro52 autoantigen as detected by a panel of novel Ro52-specific monoclonal antibodies. J Clin Immunol. 2008;28:220\u201331.","journal-title":"J Clin Immunol"},{"key":"8850_CR41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4049\/jimmunol.179.1.26","volume":"179","author":"HJ Kong","year":"2007","unstructured":"Kong HJ, Anderson DE, Lee CH, Jang MK, Tamura T, Tailor P, et al. Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages. J Immunol. 2007;179:26\u201330.","journal-title":"J Immunol"},{"key":"8850_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114095","volume":"43","author":"YY Guo","year":"2024","unstructured":"Guo YY, Gao Y, Zhao YL, Xie C, Gan H, Cheng X, et al. Viral infection and spread are inhibited by the polyubiquitination and downregulation of TRPV2 channel by the interferon-stimulated gene TRIM21. Cell Rep. 2024;43:114095.","journal-title":"Cell Rep"},{"key":"8850_CR43","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41419-021-03989-x","volume":"12","author":"J Jin","year":"2021","unstructured":"Jin J, Meng X, Huo Y, Deng H. Induced TRIM21 ISGylation by IFN-\u03b2 enhances p62 ubiquitination to prevent its autophagosome targeting. Cell Death Dis. 2021;12:697.","journal-title":"Cell Death Dis"},{"key":"8850_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103964","volume":"89","author":"Q Zheng","year":"2025","unstructured":"Zheng Q, Qin X, Huang S, Yan Z, Liu J, Xiong Y, et al. The G9a-TRIM21 axis exacerbates diabetic renal ischemia-reperfusion injury by inducing methylation-dependent ubiquitination and degradation of FoxO3a to promote oxidative stress and pyroptosis. Redox Biol. 2025;89:103964.","journal-title":"Redox Biol"},{"key":"8850_CR45","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1093\/carcin\/bgp178","volume":"30","author":"L Peng","year":"2009","unstructured":"Peng L, Ran YL, Hu H, Yu L, Liu Q, Zhou Z, et al. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src\/FAK pathway. Carcinogenesis. 2009;30:1660\u20139.","journal-title":"Carcinogenesis"},{"key":"8850_CR46","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13659","volume":"21","author":"Y Wu","year":"2022","unstructured":"Wu Y, Wu Y, Yang Y, Yu J, Wu J, Liao Z, et al. Lysyl oxidase-like 2 inhibitor rescues D-galactose-induced skeletal muscle fibrosis. Aging Cell. 2022;21:e13659.","journal-title":"Aging Cell"},{"key":"8850_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13710","volume":"7","author":"J Yang","year":"2016","unstructured":"Yang J, Savvatis K, Kang JS, Fan P, Zhong H, Schwartz K, et al. Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment. Nat Commun. 2016;7:13710.","journal-title":"Nat Commun"},{"key":"8850_CR48","doi-asserted-by":"publisher","first-page":"4400","DOI":"10.1158\/0008-5472.CAN-22-0848","volume":"82","author":"X Lu","year":"2022","unstructured":"Lu X, Xin DE, Du JK, Zou QC, Wu Q, Zhang YS, et al. Loss of LOXL2 promotes uterine hypertrophy and tumor progression by enhancing H3K36ac-dependent gene expression. Cancer Res. 2022;82:4400\u201313.","journal-title":"Cancer Res"},{"key":"8850_CR49","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.molcel.2013.10.015","volume":"52","author":"A Millanes-Romero","year":"2013","unstructured":"Millanes-Romero A, Herranz N, Perrera V, Iturbide A, Loubat-Casanovas J, Gil J, et al. Regulation of heterochromatin transcription by Snail1\/LOXL2 during epithelial-to-mesenchymal transition. Mol Cell. 2013;52:746\u201357.","journal-title":"Mol Cell"},{"key":"8850_CR50","doi-asserted-by":"publisher","first-page":"475","DOI":"10.5483\/BMBRep.2014.47.9.128","volume":"47","author":"CW Park","year":"2014","unstructured":"Park CW, Ryu KY. Cellular ubiquitin pool dynamics and homeostasis. BMB Rep. 2014;47:475\u201382.","journal-title":"BMB Rep"},{"key":"8850_CR51","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/embr.201338025","volume":"15","author":"J Zinngrebe","year":"2014","unstructured":"Zinngrebe J, Montinaro A, Peltzer N, Walczak H. Ubiquitin in the immune system. EMBO Rep. 2014;15:28\u201345.","journal-title":"EMBO Rep"},{"key":"8850_CR52","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s13402-022-00759-5","volume":"46","author":"X Zhang","year":"2023","unstructured":"Zhang X, Wu X, Sun Y, Chu Y, Liu F, Chen C. TRIM44 regulates tumor immunity in gastric cancer through LOXL2-dependent extracellular matrix remodeling. Cell Oncol. 2023;46:423\u201335.","journal-title":"Cell Oncol"},{"key":"8850_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22368-w","volume":"12","author":"Y Muto","year":"2021","unstructured":"Muto Y, Wilson PC, Ledru N, Wu H, Dimke H, Waikar SS, et al. Single cell transcriptional and chromatin accessibility profiling redefine cellular heterogeneity in the adult human kidney. Nat Commun. 2021;12:2190.","journal-title":"Nat Commun"},{"key":"8850_CR54","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00109-023-02318-3","volume":"101","author":"L Wu","year":"2023","unstructured":"Wu L, Jia M, Xiao L, Wang Z, Yao R, Zhang Y, et al. TRIM-containing 44 aggravates cardiac hypertrophy via TLR4\/NOX4-induced ferroptosis. J Mol Med. 2023;101:685\u201397.","journal-title":"J Mol Med"},{"key":"8850_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110744","volume":"109","author":"H Qian","year":"2023","unstructured":"Qian H, Lu Z, Hao C, Zhao Y, Bo X, Hu Y, et al. TRIM44 aggravates cardiac fibrosis after myocardial infarction via TAK1 stabilization. Cell Signal. 2023;109:110744.","journal-title":"Cell Signal"},{"key":"8850_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42546-2","volume":"14","author":"A Fletcher","year":"2023","unstructured":"Fletcher A, Clift D, de Vries E, Martinez Cuesta S, Malcolm T, Meghini F, et al. A TRIM21-based bioPROTAC highlights the therapeutic benefit of HuR degradation. Nat Commun. 2023;14:7093.","journal-title":"Nat Commun"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08850-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08850-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08850-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:08:21Z","timestamp":1783400901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08850-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8850"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08850-7","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"2 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"619"}}